Agios Pharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Agios Pharma is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-1.64. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 7.10M	$ 7.40M	$ 6.71M	$ 5.61M	-
Gross Profit	$ 6.52M	$ 6.77M	$ 5.60M	$ 5.05M	-
EBIT	$ -95.94M	$ -91.32M	$ -83.81M	$ -81.02M	-
EBITDA	$ -92.18M	$ -85.92M	$ -82.31M	$ -79.40M	-
Net Income Common Stockholders	$ -95.94M	$ -91.32M	$ -83.81M	$ -81.02M	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 776.93M	$ 647.49M	$ 702.57M	$ 739.20M	$ 783.12M
Total Assets	$ 937.12M	$ 1.01B	$ 1.09B	$ 1.15B	$ 1.24B
Total Debt	$ 72.00M	$ 75.50M	$ 78.95M	$ 82.34M	$ 85.66M
Net Debt	$ -704.93M	$ -571.99M	$ -623.62M	$ -656.86M	$ -697.46M
Total Liabilities	$ 126.10M	$ 120.42M	$ 120.92M	$ 114.77M	$ 1.24B
Stockholders Equity	$ 811.02M	$ 886.84M	$ 964.24M	$ 1.04B	$ 1.10B
Cash Flow	-
Free Cash Flow	$ -72.72M	$ -60.84M	$ -66.75M	$ -95.43M	-
Operating Cash Flow	$ -72.49M	$ -61.64M	$ -66.75M	$ -95.18M	-
Investing Cash Flow	$ 95.51M	$ 39.34M	$ 47.13M	$ 57.60M	-
Financing Cash Flow	$ 847.00K	$ 1.88M	$ 237.00K	$ 2.47M	-

Currency in USD

Agios Pharma Earnings and Revenue History

Income Statement >

Agios Pharma Debt to Assets

Balance Sheet >

Agios Pharma Cash Flow

Cash Flow >

Agios Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing